Lannett Co., Inc.
(NYSE : LCI)

( )
LCI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.19%53.640.9%$2000.13m
JNJJohnson & Johnson -0.08%166.540.7%$976.26m
ABBVAbbVie, Inc. -0.04%135.101.9%$909.75m
MRKMerck & Co., Inc. -0.27%81.100.7%$859.79m
BMYBristol-Myers Squibb Co. -0.44%64.441.0%$686.20m
LLYEli Lilly & Co. 0.01%245.071.1%$623.52m
AZNAstraZeneca Plc 0.77%59.941.0%$240.90m
NVSNovartis AG -0.34%88.540.2%$195.04m
GSKGlaxoSmithKline Plc -0.90%45.280.2%$163.73m
NVONovo Nordisk A/S -0.91%96.400.1%$153.61m
VTRSViatris, Inc. -0.88%14.590.0%$139.79m
RGENRepligen Corp. 0.00%189.586.7%$99.89m
IMMXImmix Biopharma, Inc. 1.24%5.730.0%$89.89m
ALLKAllakos, Inc. 0.14%7.440.0%$87.75m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. 0.04%115.080.0%$71.65m

Company Profile

Lannett Co., Inc. engages in the development, manufacture, marketing, and distribution of generic pharmaceutical products. It offers products in different forms including capsules, tablets, liquids, powders, and sprays. The company was founded in 1942 and is headquartered in Trevose, PA.